Prnewswire Oncolytics Biotech Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire oncolytics biotech inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Oncolytics Biotech Inc Today - Breaking & Trending Today

Oncolytics Biotech Inc. Announces Details Of 2008 Annual Shareholder Meeting

CALGARY, Canada, May 5 /PRNewswire/ Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2008 Annual and Special Meeting of the Shareholders will be held on Wednesday, May 7, 2008 at 9:00 a.m. (ET) at the Yale Club of New York City, 50 Vanderbilt Ave, New York. Following the business portion of the meeting, Dr. ....

New York , United States , Erika Moran , Nick Hurst , Brad Thompson , Prnewswire Oncolytics Biotech Inc , Oncolytics Biotech Inc , Investor Relations Group , Yale Club Of New York City , Equicom Group , Special Meeting , Yale Club , New York City , Cathy Ward , Cancer Research ,

Oncolytics Biotech Inc.: Oncolytics Biotech Presents Positive Interim Safety Update from Phase 2 Triple-Negative Breast Cancer Trial at the 2021 San Antonio Breast Cancer Symposium

- No safety concerns have been noted in any trial participants - Trial builds on prior clinical data demonstrating pelareorep's ability to reverse immunosuppressive tumor microenvironments ....

Jon Patton , Mridula George , Timothy Mccarthy , Oncolytics Biotech Inc , Rutgers Robert Wood Johnson Medical School , Company Contact , Ohio State University Comprehensive Cancer Center , Rutgers Cancer Institute Of New Jersey , Securities Exchange , Prnewswire Oncolytics Biotech Inc , Antonio Breast Cancer Symposium , Rutgers Cancer Institute , New Jersey , Ohio State University Comprehensive Cancer , Medical Oncologist , Assistant Professor , Securities Exchange Act ,

Oncolytics Biotech Inc.: Oncolytics BiotechPartner Adlai Nortye Doses First Patient in Chinese Bridging Trial Evaluating Pelareorep-Paclitaxel Combination Treatment in Breast Cancer

Trial is designed to advance pelareorep's clinical development in China, the world's second-largest pharmaceutical market SAN DIEGO and CALGARY, AB, Oct. 14, 2021 /PRNewswire/ Oncolytics ....

United States , Jon Patton , Timothy Mccarthy , Adlai Nortye , Resources Breast Cancer Research Foundation , Oncolytics Biotech Inc , Company Contact , Securities Exchange , Prnewswire Oncolytics Biotech Inc , Global Head Of Business Development , Oncolytic North American , Andrew De Guttadauro , Global Head , Cancer Statistics , Cancer Research , Chinese Medical Journal , Securities Exchange Act ,

Oncolytics Biotech Reports 2021 First Quarter Development Highlights and Financial Results

Oncolytics Biotech Reports 2021 First Quarter Development Highlights and Financial Results
- AWARE-1 clinical data validate clinical development strategy by confirming pelareorep s anti-tumor mechanism of action known to be associated with improved patient outcomes and ability to synergize with checkpoint inhibitors
- Preclinical studies show that pelareorep s synergistic benefits extend across multiple classes of immunotherapeutic agents, including novel CAR T approaches in solid tumors
- Phase 2 BRACELET-1 clinical trial on track for full enrollment in Q4-2021
- Strong financial foundation with over $50 million in cash on hand and cash runway to Q4-2022
SAN DIEGO and CALGARY, AB, May 7, 2021 /PRNewswire/ Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) today announced its financial results and development highlights for the quarter ended March 31, 2021. All dollar amounts are expressed in Canadian currency unless otherwise noted. ....

United States , Comunidad Autonoma De Cataluna , Matt Coffey , Oncolytic Reovirus Pelareorep , Jon Patton , Timothy Mccarthy , Kols Aleix Prat , Oncolytics Biotech Inc , National Cancer Institute , Company Contact , Loncode Institute , American Association For Cancer Research , Merck Kga , Leiden University Medical Center , Merck Kgaa , Breast Cancer Program , Securities Exchange , Roche Group , Prnewswire Oncolytics Biotech Inc , Chief Executive Officer , Oncolytics Biotech , American Association , Cancer Research , Annual Meeting , Mayo Clinic , Key Opinion Leaders ,